AstraZeneca Asset Sale

Pfizer Inc. (NYSE: PFE) isn't showing any signs of slowing down with its M&A plans. Just days after announcing it will acquire Medivation Inc (NASDAQ: MDVN) for $14 billion, Pfizer said on Wednesday it will pay $1.5 billion to acquire AstraZeneca plc (ADR) (NYSE: AZN)'s late-stage small...